Addresses microbially derived commercially important bioactive products that are currently or soon-to-be available. This second edition includes analyses of the use of recombinant enzymes to produce biologically active molecules; insights into the biochemistry, molecular biology and production of antibiotics used as therapeutic agents; and a focuses of state-of-the art techniques for the development of new antibiotics using novel approaches and strategies.

• 70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies.
• First book to address the discovery and development of antibody therapeutics in their entirety.
• Most chapters contain experimental data to illustrate the principles described in them.
• Authors provide detailed methodologies that readers can take away with them and use in their own laboratories.